![Han Zhong Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Han Zhong Li
Directeur/Membre du Conseil chez
AIMFINITY INVESTMENT CORP. I
Profil
Dr. Han Zhong Li is an Independent Director at Aimfinity Investment Corp.
I, a Senior Vice President-Development at Eureka Therapeutics, Inc., an Independent Director at Inkstone Feibo Acquisition Corp.
and an Independent Non-Executive Director at YishengBio Co., Ltd. He is on the Board of Directors at Aimfinity Investment Corp.
I, Inkstone Feibo Acquisition Corp.
and YishengBio Co., Ltd. Dr. Li was previously employed as a Chief Financial Officer by Ascentage Pharma Group International Co., Ltd., a Deputy Director-Strategy & Portfolio Management by Bayer Pharmaceuticals Corp., a Senior Vice President by Stanford Financial Group Ltd. (Texas), and a Director & Senior Vice President by SunTrust Robinson Humphrey, Inc. He received his undergraduate degree from Washington State University, an MBA from UCLA Anderson School of Management and a doctorate degree from Boston University School of Medicine.
Postes actifs de Han Zhong Li
| Sociétés | Poste | Début |
|---|---|---|
| AIMFINITY INVESTMENT CORP. I | Directeur/Membre du Conseil | 17/03/2023 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Engages in discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases & cancer | Directeur/Membre du Conseil | - |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Corporate Officer/Principal | 01/01/2019 |
Inkstone Feibo Acquisition Corp.
 Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Anciens postes connus de Han Zhong Li
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur Financier/CFO | 01/12/2018 |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 01/07/2017 |
Stanford Financial Group Ltd. (Texas)
 Stanford Financial Group Ltd. (Texas) Investment Banks/BrokersFinance Provides financial advisory services | Corporate Officer/Principal | 01/10/2009 |
Truist Securities, Inc.
 Truist Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Directeur/Membre du Conseil | 01/06/2006 |
Formation de Han Zhong Li
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Truist Securities, Inc.
Truist Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bayer Pharmaceuticals Corp. | |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Health Technology |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Financial Group Ltd. (Texas)
Stanford Financial Group Ltd. (Texas) Investment Banks/BrokersFinance Provides financial advisory services | Finance |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Engages in discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases & cancer | Health Technology |
Aimfinity Investment Corp. I
 Aimfinity Investment Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
